Advances in the Treatment of Acute (Blastic) Leukemias

Front Matter....Pages I-XI
Introduction....Pages 1-2
New Drugs in the Treatment of Acute Leukemia....Pages 56-63
Active Immunotherapy of L 1210 Leukemia Applied After the Graft of Tumor Cells....Pages 64-75
Experimental Basis and Clinical Results of Leukemia Adoptive Immunotherapy....Pages 76-84
Present Results on Daunorubicine (Rubidomycin, Daunomycin)....Pages 3-8
Rubidomycin (or Daunomycin): A Clinicial Evaluation....Pages 9-13
The Effect of Daunomycin on Proliferation and Survival of Human Leukemic Blasts in vivo....Pages 14-19
Clinical Evaluation and Future Prospects of Asparaginase....Pages 20-27
The Place of the L-Asparaginase in the Treatment of Acute Leukemias....Pages 28-36
Clinical Experience with L-Asparaginase in Britain....Pages 37-41
Clinical Status of L-Asparaginase and Side Effects....Pages 42-45
Asparaginase: Early Clinical and Toxicology Studies....Pages 46-48
Preliminary Results of L-Asparaginase in Acute Leukemias....Pages 49-51
Further Clinical Experiences with ICRF 159....Pages 52-53
Preliminary Data on Acute Leukemia Treatment with ICRF 159....Pages 54-55
Remission Induction in Adults with Acute Myelogenous Leukemia....Pages 85-91
Induction of Remission in Acute Myeloid Leukemia....Pages 92-94
Complementary Chemotherapy in Acute Leukemia....Pages 95-108
Methods and Strategy for the Treatment 1 of Acute Lymphoblastic Leukemia....Pages 109-137
Active Immunotherapy in the Treatment of Leukemia and Other Malignant Diseases in Animals and Man....Pages 138-141
Therapy of the Blastic Phase of Chronic Granulocytic Leukemia....Pages 142-148
Blastic Crisis in Chronic Leukemia and Polycythemia vera....Pages 149-151
Treatment of Blastic Crisis in Chronic Myelocytic Leukemia....Pages 152-155
Cell Proliferation in Chronic Myeloid Leukemia under Discontinuous Treatment from Diagnosis to Blastic Crisis....Pages 156-161
Blastic Leukemia Complicating Reticulo-Sarcoma and Lympho-Sarcoma....Pages 162-166
Long-Term Survivors in Acute Leukemia....Pages 167-170
Who Should Treat Acute Leukemia?....Pages 171-175
Treatment of Acute Leukemia....Pages 176-179